• Hypersensitivity to the active substance metronidazole or other nitroimidazole derivatives or to any of the excipients listed in section 6.1.
• Pregnancy - metronidazole should not be used in the first trimester in patients with trichomoniasis or bacterial vaginosis (see section 4.6).
• Breast feeding should be discontinued for 12-24 h …
Identical in both labels. Surrounding text shown from Aurobindo Pharma - Milpharm Ltd..
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Metronidazole must not be used in patients with Cockayne syndrome. Cases of severe hepatotoxicity/acute hepatic failure, including cases with a fatal outcome with very rapid onset after treatment in …
Metronidazole is contraindicated for patients with known hypersensitivity to nitroimidazoles, metronidazole or any of the excipients listed in section 6.1.
• Known hypersensitivity to metronidazole or any of the ingredients in the tablets. • Pregnancy - metronidazole should not be used in the first trimester in patients with trichomoniasis or bacterial vaginosis (see section 4.6). • Breast feeding should be discontinued for 12-24 hours …